Search
Search Results
##search.searchResults.foundPlural##
-
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1265PDF: 767HTML: 319 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3939PDF: 758HTML: 1852 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3568PDF: 2498HTML: 1482 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2870PDF: 1446HTML: 3053Cover Letter: 209 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1392HTML: 473PDF: 828 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4065PDF: 1154HTML: 1948Fig.1: 219Fig. 2: 113Table 1: 204Table2: 220Table 3: 200 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3602PDF: 1643HTML: 2678 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2817PDF: 1013HTML: 5525 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2210PDF: 2045HTML: 194 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3721PDF: 1457HTML: 186 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1669PDF: 759HTML: 263 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2623PDF: 1614HTML: 2368Table1: 191 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3795PDF: 1668HTML: 11607Figures Haase: 203 -
-
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9110PDF: 6077HTML: 87964Fig.1b: 188Fig.1c: 192Fig.2a: 178Fig.2b: 179Fig.4: 190Fig.2c: 188Fig.3: 186Tab.1: 231Tab.2: 211Tab.3: 191Tab.4: 225Fig1a: 188 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4441PDF: 1644HTML: 3822Tables and Images: 227 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3527PDF: 896HTML: 1660figure 1: 168Untitled: 193 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2238PDF: 1052HTML: 1989Characteristic of study group: 203 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1329PDF: 617HTML: 249 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277679PDF: 1801HTML: 3873 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2083PDF: 1123HTML: 7704cover letter paper final AML: 217 -
Acquired Hemophilia A successfully treated with rituximab
1954PDF: 1150HTML: 1459Figure 1: 179 -
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1252PDF: 1004HTML: 222 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1751PDF: 1175HTML: 251 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3675PDF: 1607HTML: 80 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1096PDF: 1075HTML: 451 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1979PDF: 722HTML: 688Table1: patient's characteristics: 157Table 2: profile of each patient: 179 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3327PDF: 1244HTML: 2207







